Inventor · disambiguated record
Mohit Atul Kothare
Also filed as: KOTHARE MOHIT · KOTHARE MOHIT A · KOTHARE MOHIT ATUL
15 granted patents·8 pending applications·116 citations·filing 2007–2024
92Inventor score
Files withSIGNAL PHARM LLC12CELGENE CORP4BEAUCHAMPS MARIE G2CELGENE CAR LLC2BEAUCHAMPS MARIE GEORGES1
Top patents by PatentIndex Score
23 records- 0197US9365524B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2015·Granted Jun 14, 2016·22 cites·36 claims
- 0296US9814713B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2016·Granted Nov 14, 2017·14 cites·21 claims
- 0393US10894796B2MK2 inhibitors, synthesis thereof, and intermediates theretoCELGENE CAR LLC·Filed 2018·Granted Jan 19, 2021·8 cites·19 claims
- 0491US10189808B2Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted Jan 29, 2019·10 cites·10 claims
- 0591US8569494B2Methods of synthesis and purification of heteroaryl compoundsHARRIS ROY L·Filed 2010·Granted Oct 29, 2013·27 cites·23 claims
- 0690US8158635B2Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewithBEAUCHAMPS MARIE G·Filed 2008·Granted Apr 17, 2012·26 cites·4 claims
- 0788US2025000860A1Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2024·Application pending·0 cites
- 0885US11655257B2MK2 inhibitors, synthesis thereof, and intermediates theretoCELGENE CAR LLC·Filed 2021·Granted May 23, 2023·1 cites·10 claims
- 0985US10975039B2Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2020·Granted Apr 13, 2021·1 cites·7 claims
- 1084US10689351B2Isotopologues of 2-(tert butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2019·Granted Jun 23, 2020·1 cites·7 claims
- 1184US9079900B2Methods of synthesis and purification of heteroaryl compoundsSIGNAL PHARM LLC·Filed 2014·Granted Jul 14, 2015·5 cites·27 claims
- 1282US10226461B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2017·Granted Mar 12, 2019·1 cites·4 claims
- 1379US2022378785A1Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2021·Application pending·0 cites
- 1475US11241430B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2019·Granted Feb 8, 2022·0 cites·11 claims
- 1575US2023212137A1Solid forms of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2022·Application pending·0 cites
- 1674US11492332B2Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2021·Granted Nov 8, 2022·0 cites·12 claims
- 1771US10517873B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2019·Granted Dec 31, 2019·0 cites·3 claims
- 1865US11312699B2Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2020·Granted Apr 26, 2022·0 cites·24 claims
- 1960US2018022710A1Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamideSIGNAL PHARM LLC·Filed 2016·Application pending·0 cites
- 2051US2013034495A1Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-olBEAUCHAMPS MARIE GEORGES·Filed 2009·Application pending·0 cites
- 2147US2024228475A1Processes for the preparation of (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2022·Application pending·0 cites
- 2246US2008064876A1Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dioneMULLER GEORGE W·Filed 2007·Application pending·0 cites
- 2343US2012115890A1Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewithBEAUCHAMPS MARIE G·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →